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Recently, we showed that the Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV) VP80
protein is essential for the formation of both virion types, budded virus (BV) and occlusion-derived virus
(ODV). Deletion of the vp80 gene did not affect assembly of nucleocapsids. However, these nucleocapsids were
not able to migrate from the virogenic stroma to the nuclear periphery. In the current paper, we constructed
a baculovirus recombinant with enhanced-green fluorescent protein (EGFP)-tagged VP80, allowing visualiza-
tion of the VP80 distribution pattern during infection. In baculovirus-infected cells, the EGFP-VP80 protein is
entirely localized in nuclei, adjacent to the virus-triggered F-actin scaffold that forms a highly organized
three-dimensional network connecting the virogenic stroma physically with the nuclear envelope. Interaction
between VP80 and host actin was confirmed by coimmunoprecipitation. We further showed that VP80 is
associated with the nucleocapsid fraction of both BVs and ODVs, typically at one end of the nucleocapsids. In
addition, the presence of sequence motifs with homology to invertebrate paramyosin proteins strongly supports
a role for VP80 in the polar transport of nucleocapsids to the periphery of the nucleus on their way to the
plasma membrane to form BVs and for assembly in the nuclear periphery to form ODVs for embedding in viral
occlusion bodies.
During evolution, viral structural proteins are tested contin-
uously for the efficient transfer of viral genetic information
from cell to cell in order to spread infection optimally and to
ensure virus transmission to a new host. Hence, studying the
features and functions of viral structural proteins is crucial to
understand in detail all steps of viral infection, including entry,
intracellular transport, replication, assembly, and egress.
Baculoviruses constitute a unique group of viruses specific
for arthropods, mainly insects. Autographa californica multi-
capsid nucleopolyhedrovirus (AcMNPV), the model virus of
the genus Alphabaculovirus of the Baculoviridae family, is an
enveloped virus with a circular, double-stranded DNA genome
of 130 kbp (4) wrapped in a rod-shaped nucleocapsid. Dur-
ing the infection cycle, two types of virions are formed. Budded
virus (BV) is derived from nucleocapsids leaving the cell nu-
cleus and budding through the plasma membrane. On the
other hand, occlusion-derived virus (ODV) is formed from
nucleocapsids retained in the nucleus, where envelopment oc-
curs prior to embedding of the nucleocapsids in polyhedron-
shaped occlusion bodies (see reference 50 for a review). BV
mediates the spread of infection from cell to cell, while ODV
is responsible for horizontal virus transmission between in-
sects.
Entry of the BV form of AcMNPV into host cells is medi-
ated by clathrin-dependent endocytosis (34), although direct
fusion of BVs with the plasma membrane has also been re-
corded (14). Upon internalization, nucleocapsids are released
into the cytoplasm and immediately translocated toward the
cell nucleus by actin-mediated movement, which is driven by
the viral P78/83 capsid protein (open reading frame [ORF]
1629) and the host Arp2/3 complex (22, 42). Myosin motor
functions also appear to be involved in this process (14). Re-
cently, it has been demonstrated that AcMNPV nucleocapsids
enter the cell nucleus through nuclear pores (42). In the nu-
cleus, the nucleocapsids are uncoated, upon which early gene
transcription immediately starts (42). The nuclear viral repli-
cation factory, the so-called virogenic stroma, is a site of viral
transcription (36, 45), DNA replication (8, 26), and progeny
nucleocapsid assembly (55). Little is known about the mecha-
nisms of assembly, DNA packaging, and egress of progeny
nucleocapsids. The participation of several AcMNPV proteins
in the assembly and exit of nucleocapsids has been reviewed
(12), but their precise roles remain unclear. Furthermore, bac-
ulovirus morphogenesis is highly dependent on the host fila-
mentous-actin (F-actin) cytoskeleton (41), which is dramati-
cally rearranged upon infection. The microtubule cytoskeleton
has to be taken into account as well (18).
Recently, we have provided evidence for the involvement of
the AcMNPV VP80 structural protein in the packaging of
nucleocapsids and in their egress from the nucleus toward the
cell periphery (39). The vp80 gene is transcribed late in infec-
tion as a 2.1-kb transcript with the capacity to encode an
80-kDa protein (35). VP80 is a component of both BV (58) and
ODV (6) and was first identified as P87 in Orgyia pseudotsugata
MNPV (OpMNPV) (40). Homologues of the vp80 gene are
found only in alphabaculoviruses (12). The vp80 homologue in
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Choristoneura fumiferana MNPV (CfMNPV) is expressed as
72- and 82-kDa protein variants, and only the 82-kDa form is
associated with ODV (33). Functional analysis of a Bombyx
mori MNPV (BmMNPV) vp80 deletion mutant showed that
VP80 is essential for BV production (52), and this was con-
firmed for AcMNPV (39). More recently, interactions have
been identified between VP80 and both the viral core protein
38K (60) and the Helicoverpa armigera NPV (HearNPV)
HA100 protein (46).
To better understand the function(s) of VP80 in AcMNPV
infection, we constructed an enhanced-green fluorescent pro-
tein (EGFP)-tagged VP80 baculovirus, allowing the visualiza-
tion of VP80, to study its spatiotemporal distribution during
infection. We show that VP80 enters the cell nucleus, where it
associates with the virus-induced nuclear F-actin cytoskeleton,
which forms a highly organized three-dimensional (3D) net-
work penetrating the viral replication factories and connecting
them with the nuclear envelope. Moreover, we reveal a
paramyosin (PMYO) homology sequence in VP80 and show
that VP80 associates with one end of the nucleocapsids. Taken
together, our data support the involvement of VP80 in the
egress of progeny nucleocapsids from the virogenic stroma
toward the nuclear periphery, which is dependent on func-
tional, actin-based myosin motor functions.
MATERIALS AND METHODS
Bioinformatics-based tools. The VP80 sequence was searched against the
protein Conserved Domain Database (CDD) (37, 38) and the SMART version
6 (30, 49), Pfam hidden Markov model (HMM) (20), and SilkDB (15) databases
to identify functional protein domains. Protein domain identification is limited by
the sensitivity of the search system and the diversity of protein domains in the
databases. For this reason, the information in all databases was combined to
increase both the sensitivity and the protein diversity. Short sequence motifs,
targeting patterns, and posttranslation modification sites were also searched
using the ScanProsite (13) and MyHits (43, 44) tools on the EXPASY server (3).
Multiple sequence alignment was constructed using the MUSCLE (16) algorithm
and manually edited in JalView (59).
Cells and viruses. Spodoptera frugiperda cell type 9 (Sf9) cells (Invitrogen)
were maintained in SF900-II serum-free medium (Invitrogen) at 27°C under
standard conditions. All recombinant AcMNPV bacmids and viruses were de-
rived from the commercially available bacmid bMON1427226 (Invitrogen) or its
modified version, the Ac-vp80 bacmid (39), both propagated in the Escherichia
coli strain DH10. To facilitate VP80 immunodetection, a baculovirus with an
N-terminally Flag-tagged VP80 protein (39) was used (Ac-vp80-Flag:vp80). To
prepare ODVs, AcMNPV strain E2 (51) was used. A recombinant bacmid-
derived baculovirus with an egfp reporter gene inserted in the polyhedrin (polh)
locus under p10 promoter control and designated the wild-type genotype (Ac-wt)
(39) was used as a control.
DNA constructions. The AcMNPV vp80 ORF was cleaved from pJet1.2-vp80
(39) and subcloned between SacI and XbaI sites in plasmid pIZ (Invitrogen) to
create pIZ-vp80. Subsequently, the DNA fragment encoding the vp80 ORF was
subcloned between KpnI and XbaI sites of pEGFP-C1 (Clontech) to form
pEGFP:vp80. The error-free DNA cassette with the egfp-vp80 fusion gene was
then cleaved with NheI and XbaI from pEGFP:vp80 and subcloned into the SpeI
site of pIZ (Invitrogen) to generate plasmid pIZ-egfp:vp80.
To construct EGFP-tagged VP80 recombinant baculovirus, donor plasmid
pFastBacDUAL (Invitrogen) was modified. A 254-bp fragment of the AcMNPV
vp80 promoter sequence was amplified using the forward primer Pvp80-F (5-G
GAACAAAGGCCTGAGCTCAAAGTAAGACCTTTACTGTCC-3) and the
reverse primer Pvp80-R (5-GGTTAATTGAGCTCATAAGGTTATATCGAA
TG-3). The amplified fragment was cloned between Bst1107I and SacI sites of
pFastBacDUAL to generate pFB-Pvp80. Then, the egfp-vp80 gene was excised
from the pEGFP:vp80 plasmid and subcloned into the SpeI site of pFB-Pvp80 to
generate pFB-Pvp80-egfp:vp80. The constructs were verified by DNA sequenc-
ing. The developed expression cassette was finally transposed into the polh locus
of the Ac-vp80 bacmid (39) by following the Bac-to-Bac protocol (Invitrogen).
Screening of transposition-positive Ac-vp80-egfp:vp80 bacmids was done by a
triplex PCR as previously described (39).
Transfection-infection assays. Spodoptera frugiperda (Sf9) cells (Invitrogen)
were maintained in SF900-II serum-free medium (Invitrogen) at 27°C. Five
micrograms of bacmid DNA was used to transfect 1  106 cells with Cellfectin
II (Invitrogen). At 5 days posttransfection (p.t.), the BV-enriched culture super-
natant was centrifuged for 5 min at 2,000  g and used to infect 1.5  106 Sf9
cells. Viral propagation was followed by fluorescence microscopy at the time
points p.t. or postinfection (p.i.) indicated in the figure. The Ac-wt bacmid/virus
carrying the egfp reporter gene under the control of the p10 promoter served as
a control. To monitor BV release, 1 million cells were transfected with 5 g
bacmid DNA or infected at a multiplicity of infection (MOI) of 1 50% tissue
culture infectious dose (TCID50) unit/cell. Cell culture medium was harvested at
various time points and analyzed for the presence of infectious BV by endpoint
dilution assays. The averages of the infectious titers from three independent
transfections/infections were calculated and plotted into graphs.
Purification and fractionation of BV and ODV virions. To produce BVs, 3.0
107 Sf9 cells were infected with Ac-vp80-egfp:vp80, Ac-vp80-Flag:vp80, or
control Ac-wt virus at an MOI of 1. Six days p.i., BV-enriched medium was
collected and centrifuged at 1,500  g for 10 min. The supernatant was ultra-
centrifuged at 80,000  g (Beckman SW28 rotor) for 60 min at 4°C. The BV
pellet was resuspended in 350 l 0.1 TE (10 mM Tris, 1 mM EDTA, pH 7.5)
buffer, loaded onto a linear sucrose gradient (25 to 56%, wt/vol), and ultracen-
trifuged at 80,000  g (Beckman SW55 rotor) for 90 min at 4°C. The formed BV
band was collected and diluted in 12 ml 0.1 TE. The BV preparation was
concentrated at 80,000  g for 60 min at 4°C, and the final virus pellet was
resuspended in 150 l of 0.1 TE.
To produce ODVs, 6.0  107 Sf9 cells were coinfected with Ac-vp80-Flag:
vp80 (MOI  25 TCID50 units/cell) and AcMNPV strain E2 (51) (MOI  5
TCID50 units/cell). Five days p.i., the infected cells were harvested, and ODVs
were purified from viral occlusion bodies as previously described (7). The final
ODV pellet was resuspended in 0.5 ml of 0.1 TE. The purified BV and ODV
virions were separated into envelope and nucleocapsid fractions as described
previously (7). Final fractions were processed for SDS-PAGE and immuno-
blotted against either mouse monoclonal anti-Flag antibody (Stratagene), rabbit
polyclonal anti-VP39 antiserum (directed against the major capsid protein
[kindly provided by Lorena Passarelli, Kansas State University]), rabbit poly-
clonal anti-GP64 antiserum (directed against the BV envelope protein GP64)
(57), or rabbit polyclonal per os infectivity factor 1 (PIF-1) antiserum (directed
against PIF-1, an ODV-specific envelope protein) (46).
Immunogold labeling of nucleocapsids for EM. The BV virions were immu-
nostained against Flag- and EGFP-specific epitopes by the direct immunoelec-
tron microscopy (DIEM) technique. To this aim, BVs were adsorbed on carbon-
coated electron microscopy grids, activated with glow discharge. Grids were then
incubated on drops of 0.02% Triton X-100 in 0.1 TE (10 mM Tris, 1 mM
EDTA, pH 7.5) for 20 s to remove the virion envelope. The grids were twice
washed in 1 phosphate-buffered saline (PBS), followed by incubation with
primary mouse anti-Flag (Stratagene) or anti-EGFP (Molecular Probes) anti-
bodies, both diluted 1:1,000. Finally, the grids were washed intensively in 1 PBS
and exposed to colloidal-gold (5-nm particle)-conjugated secondary goat anti-
body (Aurion). Grids were washed again in 1 PBS and sterile distilled H2O,
contrasted on a drop of 2% phosphotungstic acid (pH 7.0) for 15 s, and dried.
Samples were observed in a Philips CM12 electron microscope.
Confocal microscopy. For confocal imaging, Sf9 cells (1.5  106) were seeded
in 35-mm glass bottom culture dishes (MatTek) and infected with either Ac-
vp80-egfp:vp80 or Ac-wt (control) virus at an MOI of 10. After a 45-min
adsorption, unbound viruses were gently washed away and fresh SF900-II serum-
free medium was added. To avoid rapid temperature changes and cytoskeleton
depolymerization at low temperatures, all procedures were performed at 27°C
with prewarmed media and solutions. Expression and the subcellular localization
of either EGFP-VP80 or EGFP alone were monitored at the time points p.i.
indicated in the figures by confocal microscopy using a Leica TCS SP2 AOBS
confocal microscope operating with an argon laser (458, 476, 488, 496, and 514
nm) and an HeNe laser (543 and 594 nm). Immediately before observation, cell
nuclei were stained with Hoechst 33342 (Invitrogen), and F-actin filaments were
stained with rhodamine-phalloidin (Molecular Probes), which does not recognize
G-actin, using the manufacturer’s protocol. Colocalization measurements ex-
pressed as both Pearson’s coefficient (PC) and intensity correlation quotient
(ICQ) values were performed in JaCoP (5) implemented in ImageJ (1). To build
up 3D isosurface volume data from 2D confocal data, 30 scans in Z-axis (400 nm
per each depth step) were merged and integrated with the help of ImageSurfer
(24). Final adjustment of volume data was done with Chimera (47) software.
For transient-expression assays, Sf9 cells (1.5  106) were seeded in 35-mm
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glass bottom culture dishes (MatTek) and transfected with 5 g of pIZ-egfp:vp80
or a pIZ-4EGFP control plasmid. At 24 h p.t., cell nuclei were stained with
Hoechst 33342 (Invitrogen), and cells were observed under a confocal micro-
scope as noted above. The pIZ-4EGFP construct was obtained from Fang Xu
(Laboratory of Virology, Wageningen University) and constructed by inserting
an HpaI and NheI EGFP cassette from pTetra-EGFP (which was a kind gift
from Christian Beetz, Universita¨tsklinikum Jena, Germany) into pIZ-EGFP-N3
between HindIII and XhoI sites. To this aim, all restriction sites were made blunt
ended.
Immunoprecipitation. To verify VP80 interaction with the host actin, Sf9 cells
(3.0  107 cells) were infected with Ac-vp80-Flag:vp80 (MOI  20). Two days
p.i., the cells were harvested and washed once in 1 PBS. The Flag-tagged
protein immunoprecipitation kit (Sigma-Aldrich) was used to precipitate protein
complexes according to the manufacturer’s protocol. Bound proteins were
analyzed on Western blots with mouse anti-Flag (Stratagene) or anti-actin
(ImmunO) antibodies. The Sf9 cells infected with Ac-wt virus (MOI  20)
were used as a negative control for immunoprecipitation reactions.
Drug treatments. To evaluate the effects of 2,3-butanedione monoxime
(BDM), a myosin motor inhibitor, and cytochalasin D (CD), an actin-depolymer-
izing drug, Sf9 cells (1  106/well) were seeded in 6-well plates and infected with
Ac-wt at an MOI of 10 under standard conditions. At 12 h p.i., BDM (Sigma) or
CD (Merck) was added to the culture media at final concentrations of 10 or 30
mM for BDM and 2 or 4 M for CD. At this time, 100-l aliquots of culture
media were taken to measure residual BV titers (baselines). The cells were
further cultivated at 27°C until 48 h p.i., when cell culture supernatants were
harvested to measure BV titers by endpoint dilution. Levels of inhibition
were calculated by the following formula: percent BV release  100%  (BV
release [with inhibitory drug]  BV baseline [with inhibitory drug])/(BV release
[without inhibitory drug]  BV baseline [without inhibitory drug]). In all exper-
iments, each measure point was obtained in triplicate, and means and standard
deviations for each experimental condition were determined and plotted into
graphs.
RESULTS
Construction of a baculovirus with EGFP-tagged VP80.
Functional analysis of the AcMNPV vp80 genome has shown
that the N terminus of VP80, in contrast to its conserved C
terminus, is permissive to engineering (39). To construct
EGFP-tagged VP80 baculovirus as a tool to study the function
of VP80, we constructed an N-terminally egfp-fused vp80 cas-
sette and transposed this into the polh locus of an Ac-vp80
replication-deficient bacmid (39) (Fig. 1Ai). Sf9 cells were
transfected with the developed Ac-vp80-egfp:vp80 bacmid to
reconstitute recombinant Ac-vp80-egfp:vp80 virus. Correct
synthesis of the EGFP-VP80 fusion protein (108.83 kDa) was
proven by Western blot analysis (data not shown). The Ac-
vp80-egfp:vp80 propagation capacity was first monitored by
FIG. 1. Construction of EGFP-displaying VP80 baculovirus and its fitness analysis. (A) Comparison of the viral replication capacities of
Ac-vp80-egfp:vp80 (a) and Ac-wt (b). (i) Diagram of the expression cassettes transposed into the polh locus of a vp80-deleted (a) or an Ac-wt
(b) bacmid. (ii) Time course fluorescence microscopy showing the propagation of the infection in Sf9 cells transfected with the resulting bacmid
constructs. The progress of viral infection was checked by EGFP detection (converted to white) at the indicated times p.t. At 120 h p.t., the cell
culture supernatants were collected to initiate a secondary infection. (iii) Secondary infection assay. (B) One-step growth curves of both the
Ac-vp80-egfp:vp80 and Ac-wt constructs following transfection (a) or infection (MOI  1) (b). Cell culture supernatants were harvested
at the indicated times p.t. or p.i. and analyzed for the release of infectious BV by endpoint dilution. Infectivity was monitored by EGFP
expression. The points indicate the average titer derived from three independent transfections/infections, and the error bars represent the
standard deviations (SD).
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fluorescence microscopy (Fig. 1Aii to iii). The results showed
widespread egfp-vp80 expression, indicating that the reconsti-
tuted EGFP-VP80-producing virus is able to efficiently spread
from cell to cell. We did not observe any replication handicap
of the EGFP-tagged virus compared with the replication ca-
pacity of Ac-wt. Accordingly, determination of growth curves
of Ac-vp80-egfp:vp80 virus showed replication kinetics simi-
lar if not identical to those of Ac-wt propagation (Fig. 1B). The
results thus confirmed that the N terminus of VP80 is highly
permissive to engineering to display foreign peptide/protein,
without any negative effects on viral fitness, at least in cell
culture.
VP80 is linked to one end of nucleocapsids. The VP80 pro-
tein has been shown to be a component of both BV (58) and
ODV (6). To determine whether VP80 is a component of
nucleocapsid or envelope, Ac-vp80-Flag:vp80 BV was frac-
tionated into nucleocapsid and envelope fractions. Final frac-
tions were subjected to Western blot analysis. Flag-VP80 was
detected only in the nucleocapsid fraction as a band of 80
kDa (Fig. 2A, upper panel). Correct separation of BV into
nucleocapsid and envelope fractions was checked with antibod-
ies against the major capsid protein (VP39) and the BV enve-
lope protein (GP64) (Fig. 2A, middle and lower panels). In
order to demonstrate that VP80 is also an ODV nucleocapsid-
associated protein, Sf9 cells were coinfected with Ac-vp80-
Flag:vp80 and wild-type (polyhedron-producing) AcMNPV vi-
ruses. Five days p.i., ODV virions were released from produced
polyhedra and analogously separated into nucleocapsid and
envelope fractions. Western blot analysis proved that VP80 is
associated with ODV-derived nucleocapsids and that it mi-
grates as a single band of 80 kDa (Fig. 2B, upper panel).
Proper fractionation into nucleocapsid and envelope fractions
was verified using anti-PIF-1 antiserum, recognizing an ODV
membrane-specific protein (Fig. 2B, lower panel).
To explore VP80 localization in more detail, direct immu-
noelectron microscopy was carried out to locate VP80 on the
nucleocapsid structure. Nucleocapsid rods derived from BVs
of either Ac-vp80-egfp:vp80 or Ac-vp80-Flag:vp80 were
prepared to facilitate VP80 immunodetection. EM observa-
tions showed that gold particles specifically localized to one
end of the nucleocapsids (Fig. 2Ca and b), with use of anti-Flag
and anti-EGFP antibody, respectively. The pattern was the
same for both tested BVs (Ac-vp80-Flag:vp80 and Ac-vp80-
egfp:vp80). No gold labeling was observed when control Ac-wt
BV-derived nucleocapsids were analyzed (Fig. 2Cc and d). The
EM results indicate that VP80 is anchored to one end of the
nucleocapsid. Due to electron microscope resolution limits, we
are not able to provide information about whether VP80 pref-
erentially associates with the basal region or the apical end of
the nucleocapsid.
VP80 is present in a highly organized 3D network in cell
nuclei. The spatiotemporal distribution of VP80 during viral
infection was analyzed by live time course imaging. Sf9 cells
were infected with the Ac-vp80-egfp:vp80 virus (producing
EGFP-fused VP80), followed by confocal imaging (Fig. 3A).
Confocal observation showed that EGFP-VP80 strongly accu-
mulates in the nuclei of infected cells, where it forms or asso-
ciates with a distinct structure(s), which became more apparent
later in infection. EGFP-VP80 production was almost unde-
tectable until 12 h p.i., when EGFP-VP80 was mostly homo-
geneously distributed in cell nuclei but started to accumulate at
distinct spots around the DNA-enriched core, the viral repli-
cation factory, or “virogenic stroma” (Fig. 3Ai). The EGFP-
VP80 spots colocalized with DNA-labeled loci, suggesting a
potential function of VP80 in DNA genome processing and
packaging into capsids. At this time, in a certain number
(5%) of infected cells, thick VP80- and DNA-containing
FIG. 2. VP80 copurifies with nucleocapsids of both BV and ODV
virions and is associated with one end of the nucleocapsid. (A) Ac-
vp80-Flag:vp80 BV virions were separated into nucleocapsid (Nc)
and envelope (Env) fractions. The Flag-VP80 protein was detected on
immunoblots with anti-Flag antibody (upper panel). Correct separa-
tion into Nc and Env fractions was controlled with anti-VP39 and
anti-GP64 antibodies (bottom panels). (B) The ODV virions produced
in Sf9 cells coinfected with the Ac-vp80-Flag:vp80 (MOI  25) and
AcMNPV strain E2 (MOI  5) viruses were separated similarly into
Nc and Env fractions and immunoblotted with anti-Flag antibody
(upper panel). Proper fractionation was controlled using anti-PIF-1
antiserum (bottom panel). Equal amounts of protein (10 g) were
loaded in the lanes. (C) Immunoelectron microscopy of BV nucleo-
capsids derived from either the Ac-vp80-Flag-vp80 (a) or Ac-vp80-
egfp:vp80 (b) genotype. (c, d) Nucleocapsids purified from the Ac-wt
genotype-propagated BVs were used as a negative control. Purified
nucleocapsids were adsorbed to EM grids and immunostained with
mouse anti-Flag (a, c) or anti-EGFP (b, d) antibody, followed by goat
anti-mouse immunoglobulin conjugated with 5-nm gold particles. The
black arrowheads point to specific localizations of 5-nm gold particles.
Bars represent 200 nm.
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FIG. 3. Baculovirus VP80 enters the cell nucleus. (A) Confocal microscopy of Sf9 cells infected with Ac-vp80-egfp:vp80 virus (MOI  10)
expressing EGFP-fused VP80 (green) and stained with Hoechst 33342 for DNA (magenta). The cells were observed at 12 h (i), 24 h (ii), and 60 h
(iii) p.i. The white open arrowheads point at colocalization sites of EGFP-VP80- and DNA-labeled regions. (B) Transient expression of
EGFP-VP80. Confocal microscopy of Sf9 cells transfected with the pIZ-egfp:vp80 (green) (i) or pIZ-4EGFP (green) (ii) plasmid and stained with
Hoechst 33342 for DNA (magenta). The cells were observed at 24 h p.t. Dashed lines represents cell surfaces. All images were collected in green
(a) and blue (b) channels and merged (c), and, finally, 3D reconstructions of confocal Z-stack data sets were performed (d). Signals from the blue
channel are expressed in magenta for better visualization. Abbreviations: cm, cytoplasmic membrane; cy, cytoplasm; ne, nuclear envelope; nu,
nucleus; pr, VP80 protrusion-like structures; rz, ring zone; vs, virogenic stroma. Scale bars represent 10 m.
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filaments directing toward the nuclear periphery were ob-
served (data not shown). In the late phase of infection (24 h
p.i.), the strongest EGFP-VP80 signal was localized in the
central region of cell nuclei, suggesting the association of
EGFP-VP80 with the virogenic stroma (Fig. 3Aii). At this time
point, the EGFP-VP80 distribution pattern showed distinct
protrusions, routing from the center of the nucleus toward the
nuclear envelope (Fig. 3Acii). The intensity of the EGFP-VP80
signal was maximal in the central area of the nucleus, presum-
ably the virogenic stroma region, and gradually decreased to-
ward the ring zone and the contacting nuclear envelope. The
term “ring zone” defines a peristromal region enclosing the
virogenic stroma inside the baculovirus-infected cell nucleus.
Typically, this is the place where ODV virions are embedded
into viral occlusion bodies (50).
With 3D reconstructions of confocal Z-stack data sets, the
EGFP-VP80 architecture appeared to form a star-like struc-
ture with a highly dense core and protrusions pointing toward
the ring zone area and from there toward the nucleus periph-
ery (Fig. 3Adii). Occasionally, crossing of individual beams
resembling a highly organized web-like structure could be
seen. In the very late phase of infection (60 h p.i.), the EGFP-
VP80 signal was still concentrated in the central region of cell
nuclei (virogenic stroma localization). Nevertheless, the typical
protrusions connecting the virogenic stroma with the nuclear
periphery had disappeared (Fig. 3iii). Importantly, no EGFP-
VP80 signal was observed by confocal imaging in the cytoplasm
at any time point during infection, indicating that VP80 protein
is very efficiently targeted into the cell nucleus immediately
after synthesis. It is important to mention that a similar VP80
distribution pattern was observed by indirect immunofluores-
cence using a baculovirus with Flag-tagged VP80, preclusive of
artifacts due to EGFP fusion (data not shown).
To verify the specificity of observed phenotypes, Sf9 cells
were infected with Ac-wt virus (expressing egfp alone) and also
subjected to confocal imaging. In this experiment, we observed
a homogenous distribution of the EGFP signal in both the
cytoplasmic and nuclear compartments, as has been observed
before (e.g., reference 61).
VP80 localization in the absence of viral infection. When
EGFP-VP80 was transiently expressed in insect cells in the
absence of any other viral protein, nuclear localization of
EGFP-VP80 was seen again (Fig. 3Bi). On the other hand, no
nuclear labeling was observed when 4 EGFP (a protein of
the same size as the EGFP-VP80 fusion protein) was produced
alone (Fig. 3Bii). The results demonstrate that VP80 has an
active nuclear localization signal (NLS), which is in accordance
with bioinformatic predictions (putative bipartite NLS amino
acids [aa] 424 to 439). Notably, transiently expressed EGFP-
VP80 did not occupy or form any distinct intranuclear struc-
tures in insect cells, as has been seen in baculovirus-infected
cells. The results collected so far suggest that intranuclear
VP80-specific structures seen during infection are the conse-
quence of complex recruitment and orchestration of viral, and
possibly cellular, factors (e.g., the host cytoskeletal proteins)
but not of VP80 alone.
Myosin-like sequences in VP80. To further elucidate the
function of VP80 in the viral replication cycle, the VP80 se-
quence has been searched against protein databases to identify
putative functional domains. No unique conserved domain has
been definitively revealed; however, most homology-based
tools pointed out a relationship with actin cytoskeleton-inter-
acting proteins, especially with proteins in the myosin protein
family. For instance, using the PSI-BLAST (2) approach, a
similarity between VP80 and tail domains of myosin proteins
was identified, while the SMART server (29) revealed a certain
resemblance with myosin motor domains. The MyHits tool on
the EXPASY server revealed an IQ-like motif, which is a
calmodulin-binding domain present in all myosin motor pro-
teins, in the C-terminal region (aa 575 to 597) of VP80 (Fig.
4B). On the other side, a myosin motor-specific ATP-binding
motif (P-loop) responsible for the coordination and hydrolysis
of ATP was not identified in VP80.
When AcMNPV VP80 or its homologue in Bombyx mori
NPV (BmNPV) was searched against the Bombyx mori genome
database (15), an obvious similarity to the paramyosin
(PMYO) protein was identified. Similarity was also found with
the Aedes aegypti PMYO protein (Fig. 4A). For instance,
AcMNPV and BmNPV VP80 sequences from Glu164-Glu368
showed 21% and 23% identity, respectively, to the B. mori
PMYO sequence Glu168-Glu380. Thus, the in silico searches
provided information that baculovirus VP80 is more a putative
paramyosin-like or myosin tail-like protein than an active my-
osin motor protein. Interestingly, cellular paramyosin mole-
cules are essential components of the invertebrate actin-myo-
sin (acto-myosin) complex (17).
Late events in AcMNPV infection are susceptible to BDM
and CD. As recently shown (39), VP80 is involved in the
transport of progeny nucleocapsids, since deletion of the vp80
gene completely prevents transit of de novo-assembled nucleo-
capsids toward the nuclear periphery to form viral progeny
(BVs and ODVs). These findings, together with the fact that
VP80 contains a paramyosin-like domain, led us to the theory
that progeny nucleocapsids may be transported toward the
nuclear periphery with the help of an acto-myosin complex. To
verify this hypothesis, cells in the late phase of AcMNPV
infection were treated either with BDM, a myosin motor-spe-
cific inhibitor, or CD, an actin-depolymerizing agent. For these
purposes, Sf9 cells were infected with Ac-wt and cultured un-
der standard conditions. At 12 h p.i., inhibitors were added at
various concentrations (Fig. 5C) to the culture media, and BV
production was measured in culture supernatants at 48 h p.i.
The presence of each type of inhibitor resulted in a significant
inhibition of BV release. The presence of 10 mM BDM re-
duced BV production to 76% 	 6% and a 30 mM concentra-
tion even reduced production to 34% 	 8% of the level in
untreated control cells (considered 100%) (Fig. 5C). Similar
results were obtained with CD, which reduced BV release to
59% 	 7% (2 M) and to 19% 	 3% (4 M) of the control
level. The inhibition assays thus support the hypothesis that
late events of AcMNPV infection, such as maturation of nu-
cleocapsids and their movement toward the cell periphery and
subsequent BV budding, are dependent on actin-based myosin
motor functions.
VP80 and F-actin provide traffic connections between the
viral replication factory and the nuclear periphery. To be able
to link VP80 functions to actin-based movement, we studied its
interactions with the host actin cytoskeleton. To this end, Sf9
cells were infected with the Ac-vp80-egfp:vp80 virus and
EGFP-VP80 localization was analyzed in relation to the F-ac-
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tin cytoskeleton by confocal imaging. First, baculovirus infec-
tion caused dramatic changes in F-actin network architecture
(Fig. 5A), as was shown for the first time by Ohkawa and
Volkman (41). Importantly, confocal imaging showed remark-
able overlapping distributions of VP80 and F-actin filaments in
baculovirus-infected cells (Fig. 5A). Again, the EGFP-VP80
signals were observed only in cell nuclei, where they apparently
colocalized with the virus-induced F-actin networks (Fig. 5Ai).
Interaction between VP80 and actin was subsequently shown
by immunoprecipitation, when host actin was specifically co-
purified with Flag-tagged VP80 protein (Fig. 5B).
Based on these observations, the question of whether VP80
is involved in the establishment of the virus-induced, nuclear
F-actin network was raised. To answer this, Sf9 cells were
transfected with either Ac-vp80 or Ac-wt bacmid, and F-actin
architectures were compared by confocal microscopy. Here, we
did not note any dramatic differences in F-actin architectures
formed in the absence or presence of VP80 (data not shown).
From these data, we concluded that VP80 forms complexes
with the host F-actin cytoskeleton but is not necessary for the
(re)arrangement of the latter.
Confocal imaging at high magnification revealed that the
VP80 protein together with F-actin cables penetrates and en-
closes the virogenic stroma, the site of virus replication (Fig.
6A). We could observe overt actin-built-up cables permeating
the virogenic stroma and going toward its periphery, which
were accompanied by the VP80 protein (Fig. 6A). These actin-
VP80 tracks apparently connected the virogenic stroma with
the nuclear periphery. Furthermore, the F-actin cables ap-
peared to continue toward the cell periphery, while VP80 sig-
nal was limited to the nuclear compartment. A colocalization
assay provided a spatial map of the overlapping distribution of
VP80 with the F-actin cytoskeleton (Fig. 6B). Relatively low
values of calculated PC (0.45) and ICQ (0.19) (values of 1 and
0.5, respectively, represent complete colocalization) indicate
that VP80 does not directly decorate F-actin filaments but
more probably coaligns with or localizes to them at distinct
regions. An analogous colocalization assay was done for VP80
and DNA to demonstrate an interaction of VP80 with the
virogenic stroma. This analysis provided an encircled colocal-
ization pattern with several highly organized spots inside the
virogenic stroma (Fig. 6C).
Finally, 3D reconstruction of Z-stack confocal data im-
proved our view on the architecture of baculovirus-infected
cells (Fig. 7A). Taken together, our findings show that VP80
protein and F-actin cytoskeleton interact and provide traffic
connections between the virogenic stroma and nucleus pe-
riphery, presumably to facilitate egress of progeny nucleo-
capsids.
DISCUSSION
In this paper, we studied properties of the AcMNPV VP80
minor capsid protein, its localization on the nucleocapsid, and
the kinetics of its subcellular distribution during infection in
insect Sf9 cells. We also addressed the question of whether any
sequence similarities and, eventually, functional domain topol-
ogies between VP80 and proteins deposited in the protein
databases can be found.
To address these issues, we engineered the knockout Ac-
vp80 bacmid to encode “visible” EGFP-tagged VP80 protein.
One-step growth kinetics showed that introduction of the egfp-
vp80 cassette completely rescued virus replication to the wild-
type level (Fig. 1), indicating that fusion of EGFP to VP80
FIG. 4. VP80 contains paramyosin-like and myosin-like sequence motifs. (A) Alignment of AcMNPV-VP80 and BmMNPV-VP80 (both with
the sequence Glu164-Glu368) with corresponding sequences of paramyosin proteins: Bombyx mori PMYO (Bm-PMYO) (GenBank accession no.
XP_637740.1) and Aedes aegypti PMYO (Aeae-PMYO) (XP_001652576.1). (B) AcMNPV VP80 sequence Tyr575-Phe597 aligned with experimen-
tally verified IQ motifs (calmodulin-binding domains) from selected myosin motor proteins: Dictyostelium discoideum MYO2 (Didi-MYO2)
(XP_637740.1), Chara corallina MYO (Chco-MYO) (BAB03273.1), Arabidopsis thaliana MYO (At-MYO) (CAA84066.1), Nicotiana tabacum
MYO11 (Nita-MYO11) (BAD72949.1), Drosophila melanogaster MYO (Dm-MYO) (CAA47462.1), Xenopus tropicalis MYO6 (Xetr-MYO6)
(AAI21230.1), Danio rerio MYO6a (Dare-MYO6a) (AAT92221.1), Mus musculus MYO6 (Mm-MYO6) (NP_001034635.2), and Homo sapiens
MYO6 (Hs-MYO6) (NP_004990.3). The alignments were constructed using MUSCLE, and coloring was performed in JalView.
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does not negatively affect virus fitness, at least in cell culture.
More specifically, we show that the N terminus of VP80 can be
targeted to engineer novel virus vectors with designated prop-
erties. The constructed Ac-vp80-egfp:vp80 virus was then em-
ployed as a tool to explore VP80 localization on the nucleo-
capsid structure, as well as its spatiotemporal distribution
during infection.
Immunolabeling of BV-derived nucleocapsids showed that
VP80 preferentially associates with one end of the nucleocap-
sid (Fig. 2), indicating a potential interaction/cooperation with
other nucleocapsid end-linked proteins: P78/83 (54) and
VLF-1 (53). The polarity of nucleocapsids is in line with earlier
observations that ODV nucleocapsids are anchored at one
specific end (the cap structure) to envelopes present in the
nucleus (21). In infected cells, EGFP-VP80 was observed en-
tirely in the nucleus, and the distribution pattern changed over
time (Fig. 3). Initially (12 h p.i.), the EGFP-VP80 signal was
homogenously spread throughout the nucleus but subsequently
started to colocalize with DNA-containing areas protruding
from the virogenic stroma. In the late phase of infection (24 h
p.i.), the EGFP-VP80 pattern showed obvious connections be-
tween the central area of the nucleus and the nuclear periph-
ery. Interestingly, these EGFP-VP80 tracks that connect the
center of the nucleus with the nuclear envelope completely
disappeared in the very late phase of infection (60 h p.i.).
These spatiotemporal changes in VP80 distribution might ap-
FIG. 5. VP80 interacts with the virus-triggered, nuclear F-actin cytoskeleton. (A) Confocal microscopy of Sf9 cells infected with Ac-vp80-
egfp:vp80 virus (MOI  10) (i) and uninfected Sf9 cells (ii). At 24 h p.i., the cells were fixed and stained with Hoechst 33342 for DNA (blue) and
with phalloidin-rhodamine for F-actin (red). All images were collected in green (a), red (b), and blue (c) channels, and, finally, 3D reconstructions
of confocal Z-stack data sets were performed (d). The dashed boxes point out overlapping distributions of EGFP-VP80 protein and nuclear F-actin.
Scale bar, 10 m. (B) VP80 associates with host cell actin. Sf9 cells were infected with Ac-vp80-Flag:vp80 (MOI  20), and Flag-VP80 protein
was coimmunoprecipitated at 48 h p.i. (CoIP:anti-Flag). Proteins bound to the anti-Flag antibody were analyzed by immunoblotting with anti-Flag
and antiactin antibodies. In the experiment, Sf9 cells infected with the Ac-wt virus (MOI  20) were used as a negative control. Cell lysates are
shown as input. WB, Western blot. (C) Sensitivity of AcMNPV infection to BDM and CD treatment. Sf9 cells were infected with Ac-wt and treated
with BDM and CD as indicated. BVs were quantified in cell culture supernatants at 48 h p.i. by endpoint dilution. Results of three independent
assays, with error bars giving the SD, are shown.
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parently be the result of sophisticated baculovirus regulation,
functioning as a two-throw switch between the production of
two virion types: extracellular BV (late) and intranuclear ODV
embedded in viral occlusion bodies (very late).
Confocal imaging showed that EGFP-VP80 accumulates in the
nucleus. No EGFP-VP80 signal was observed in the cytoplasm at
any time point during infection (Fig. 3 and 5 to 6). This finding is
not in agreement with our observations showing the association of
EGFP-VP80 with nucleocapsids of both virion types (Fig. 2),
theoretically making it possible to detect EGFP-VP80 during
nucleocapsid transit through the cytoplasm toward the cell pe-
riphery to form BV. The observed inconsistency might be ex-
plained by a low abundance of nucleocapsid-bound EGFP-VP80,
which is under the detection threshold of confocal microscopy.
FIG. 6. Colocalization of VP80 with F-actin filaments connecting the virogenic stroma with the nuclear envelope. (A) Confocal microscopy of
Sf9 cells infected with Ac-vp80-egfp:vp80 (MOI  10) expressing EGFP-fused VP80 (green). At 24 h p.i., the cells were fixed and stained with
Hoechst 33342 for DNA (blue) and with phalloidin-rhodamine for F-actin (red). The images were collected in green (a), red (b), and blue (c)
channels and differentially merged (d to f), and, finally, 3D reconstructions of confocal Z-stack data sets were performed (g). (B) Colocalization
of EGFP-VP80 with nuclear F-actin. (C) Colocalization of EGFP-VP80 with DNA-labeled regions. For panels B and C, the green and red channels
from the inset from panel Aa were merged (a). Colocalization regions are depicted in white (b to c). (B and C) The colocalization proportions
as represented by PC and ICQ values were plotted into graphs (d). Abbreviations: ac, cytoplasmic F-actin cables; cm, cytoplasmic membrane; cy,
cytoplasm; ne, nuclear envelope; rz, ring zone; vs, virogenic stroma. Scale bars represent 10 m.
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FIG. 7. VP80 and the nuclear architecture of baculovirus-infected cells. (A) 3D isosurface rendering based on confocal data. Sf9 cells infected
with the Ac-vp80-egfp:vp80 virus (green) were fixed and stained with Hoechst 33342 for DNA (blue) and with phalloidin-rhodamine for F-actin
(red) and imaged simultaneously by confocal microscopy. The volume data were generated from 30 scans in the Z-axis, using 400 nm per each
depth step. The signals are shown separately (a to c) and together (d to g) to demonstrate the intranuclear localization of VP80 to the F-actin
cytoskeleton and the DNA-labeled area (virogenic stroma). Abbreviations: cm, cytoplasmic membrane; ne, nuclear envelope. Scale bar, 10 m.
(B) Model for the function of VP80 protein in the baculovirus infection cycle based on the intracellular distribution of VP80, its association with
the F-actin cytoskeleton, the vp80 phenotype, and the sensitivity of AcMNPV infection to BDM treatment. In Ac-wt-transfected cells (a), a high
number of DNA-filled progeny nucleocapsids are transported along F-actin to the cell periphery to form both BV and ODV virions, whereas in
vp80-transfected cells (b), DNA encapsidation is affected and nucleocapsid release from the virogenic stroma is completely prevented. VP80 is
depicted in contact with viral nucleocapsids, nuclear F-actin filaments, and virogenic stroma.
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Colocalization of VP80 with DNA can indicate that VP80 is
a part of a DNA-interacting protein complex or has the ability
to bind DNA itself. At the later time (24 h p.i.), EGFP-VP80
was present in a 3D network penetrating and connecting the
virogenic stroma with the nuclear envelope. These observa-
tions support the hypothesis that VP80 is somehow involved in
the packaging of nucleocapsids, which is further based on the
relatively high number of only partially DNA-filled capsids
(absence of mature capsids) observed in vp80-transfected
cells (39). In addition, VP80-containing tracks linking the vi-
rogenic stroma with the nuclear envelope strongly suggest the
involvement of VP80 in progeny virus egress. These findings
are in accordance with those of our previous study, where we
revealed that deletion of vp80 totally prevents the transport of
de novo-assembled nucleocapsids from the virogenic stroma
toward the nuclear periphery (39).
In order to identify functional domains, we compared the
VP80 sequence with sequences in protein databases. Unex-
pectedly, a certain similarity was identified between VP80 and
the invertebrate paramyosin protein family (Fig. 4A). Strong
indications for interactions between viruses and host myosin
motors exist (19, 28, 48, 62), but to date, no paramyosin-like
proteins have been identified in any viral genome. The
paramyosins are a major structural component of muscular
thick filaments in a diverse range of invertebrate species, in-
cluding insects (reviewed in, e.g., reference 23). In general,
paramyosins form cofilaments with myosin motor proteins
(thick filaments), which interact with actin-based (thin) fila-
ments to convert chemical energy (ATP) into mechanical force
(e.g., movement). Importantly, the molar ratio between myosin
motors and paramyosin molecules in thick filaments has a
crucial impact on the performance of the acto-myosin complex
(23). These facts led us to formulate a model scenario (Fig. 7B)
where nucleocapsid-linked VP80, a baculovirus paramyosin-
like protein, is responsible for interaction with the host acto-
myosin complex to facilitate active, directed nucleocapsid
transport. In principle, this is nothing unusual, as similar mac-
romolecular assembly movements are frequently executed in
cell nuclei, for instance, to export ribosomal subunits (11) or to
drive movement of transcription complexes along a DNA tem-
plate (32, 63). The conserved AcMNPV ODV (6) and BV (58)
protein encoded by orf66 (Ac66) has been reported to possess
homology to the actin-binding domain of myosin VI (56). De-
letion of this gene gives a phenotype similar to that of a vp80
deletion mutant, with impaired nucleocapsid egress from the
nucleus as well as a block in ODV synthesis (25). We hypoth-
esize that VP80 and Ac66 may work in concert to transport
progeny nucleocapsids to the nuclear periphery.
To test our hypothesis that the acto-myosin complex is
important for progeny nucleocapsid transport, we treated
AcMNPV-infected cells (at 12 h p.i., the initial time of progeny
egress) with either BDM or CD and checked inhibition effects
on progeny BV production. We could see strong inhibitory
effects on BV release using each drug (Fig. 5C), demonstrating
a significant contribution of the host acto-myosin complex in
progeny virus egress and budding. It has previously been shown
that transport of parental AcMNPV nucleocapsids to and/or
into the nucleus is facilitated by the host acto-myosin complex
(14, 27, 42). Herein, we provide evidence for participation of
the actin-based myosin motor functions also in late events
(such as egress and budding) of AcMNPV infection. Never-
theless, it has to be taken into account that the BDM-triggered
decrease in BV production might also be the result of side
effects of the drug (e.g., Ca2
 release from the endoplasmic
reticulum, etc).
To extend our theory, we looked at a potential in vivo inter-
action between VP80 and the host actin cytoskeleton. Upon
AcMNPV infection, we could see a typical rearrangement of
the F-actin filaments (Fig. 5A). More interestingly, the nuclear
EGFP-VP80 pattern evidently accompanied the virus-trig-
gered F-actin network, confirming our assumptions. Detailed
views into the nucleus revealed that VP80 and F-actin fila-
ments together penetrate and link the virogenic stroma with
the nuclear periphery (Fig. 6). VP80 localization was limited to
the nucleus, while F-actin filaments were seen going out of the
nucleus and continuing toward the cell periphery. Additionally,
immunoprecipitation assays proved that VP80 forms com-
plexes with host actin (Fig. 5B). It remains unclear whether
VP80 directly interacts with or is part of a protein complex
interacting with the actin cytoskeleton. However, our colocal-
ization measurement implies that VP80 does not tightly deco-
rate actin filaments but more probably coaligns with them at
certain distances. Taken together, we provide evidence that
AcMNPV VP80 is a newly identified baculovirus actin-inter-
acting capsid protein, next to major capsid protein VP39 (9,
10), Wiscott-Aldrich Syndrome Protein (WASP) homology
phosphoprotein P78/83 (27), and BV/ODV C42 (31).
Baculoviruses replicate and package their viral DNA ge-
nomes inside the nuclei of infected cells; hence, transport to
and away from the nucleus is a pivotal task of their evolution-
ary success. A previous study by Ohkawa and coworkers (42)
clearly demonstrated that AcMNPV parental nucleocapsids
are capable of undergoing undirected, actin-based motility (by
means of so-called actin comets) in the cytoplasm to reach the
cell nucleus. We do not suppose that this kind of transport is
used by progeny nucleocapsids to egress the cell nucleus be-
cause of the highly organized structure of the nucleus. Espe-
cially in baculovirus-infected cells, where the nuclei are mark-
edly enlarged and the highly dense virogenic stroma represents
a labyrinth for progeny nucleocapsids, undirected actin comet-
based motility does not appear to be effective. Our data col-
lected so far imply that the escape of progeny nucleocapsids
from the virogenic stroma toward the nuclear periphery, and
maybe even further toward the cell periphery for BVs, is me-
diated by a more directed transit, in which both F-actin and
myosin motor functions are included. In addition, there is also
recent evidence for involvement of the microtubule cytoskele-
ton in baculovirus progeny egress (18). Hence, it seems that
microfilaments and microtubules mutually contribute to the
efficient transport of progeny nucleocapsids from the nucleus
toward the cell periphery.
Therefore, future research should address the following
tasks. Which host myosin motor proteins interact with baculo-
virus capsid proteins, e.g., VP80? How do these interactions
mediate the movement and budding of progeny nucleocapsids?
How is transport of viral nucleocapsids timed along F-actin
filaments (BV versus ODV phenotype)? Another intriguing
question is how baculoviruses in other genera (Betabaculovirus,
Gammabaculovirus, and Deltabaculovirus) that do not encode
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VP80 manage to transport their nucleocapsids to the nuclear
periphery.
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